Top Markets
#1 MowCat MowCat +777.40%
#2 龙虾 (Lobster) 龙虾 (Lobster) +88.11%
#3 SIXSEVEN SIXSEVEN +49.97%
#4 Magma Finance Magma Finance +40.57%
#5 Akedo Akedo +39.02%
#6 MarsCoin MarsCoin +36.09%
#7 Cortex Cortex +26.18%
#8 DeXe DeXe +23.56%
#9 OpenEden OpenEden +13.51%
#10 Pons Pons +12.07%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Classifica tra le azioni #8284
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Prezzo delle azioni
$24.37
Capitalizzazione di mercato
$1.30B
Variazione (1 giorno)
-7.16%
Variazione (1 anno)
-
Paese
US
Scambia Seaport Therapeutics, Inc. Common Stock (SPTX)

Categoria

Healthcare
Utile per Seaport Therapeutics, Inc. Common Stock (SPTX)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Seaport Therapeutics, Inc. Common Stock, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Seaport Therapeutics, Inc. Common Stock dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH